MiMedx Group, Inc
$4.77
$0.08 (+1.71%)
$4.61Day Range$4.79
Key Statistics
Market Cap
$696.11M
Shares Outstanding
145.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 22, 2007
Round Lot
100
Locale
US
Trading Data
Day Open
$4.65
Day High
$4.79
Day Low
$4.61
Volume
3.90M
VWAP
$4.76
Prev Close
$4.69
Transactions
--
Acc. Volume
--
About MiMedx Group, Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841808 employees1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062(770) 651-9100IPO Aug 22, 2007US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001376339
- Composite FIGI
- BBG000RJ6FL5
- Share Class FIGI
- BBG001STPW96
- Ticker Root
- MDXG
- SIC Code
- 3841
About MiMedx Group, Inc (MDXG) Stock
MiMedx Group, Inc (MDXG) closed the 2026-09-18 session at $4.77, up 1.71% versus the previous close (+0.08). The stock opened at $4.65 and traded between $4.61 and $4.79 during that session. Session trading volume was 3.9M shares. The volume-weighted average price (VWAP) is $4.76.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
MiMedx Group, Inc has a market capitalization of $696.1 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. MDXG is listed on the XNAS exchange. The company employs approximately 808 people. MiMedx Group, Inc is headquartered in MARIETTA, GA. The recorded listing date is 2007-08-22.
On this page you can find market MDXG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.